This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Jan;43(2):228-30.

doi: 10.1016/j.ejca.2006.10.002. Epub 2006 Nov 14.

The weakest link

PMID: 17107782
DOI: 10.1016/j.ejca.2006.10.002

Editorial

The weakest link

Abram Recht. Eur J Cancer. 2007 Jan.

. 2007 Jan;43(2):228-30.

doi: 10.1016/j.ejca.2006.10.002. Epub 2006 Nov 14.

Author

PMID: 17107782
DOI: 10.1016/j.ejca.2006.10.002

No abstract available

PubMed Disclaimer

Comment on

Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.
Ringberg A, Nordgren H, Thorstensson S, Idvall I, Garmo H, Granstrand B, Arnesson LG, Sandelin K, Wallgren A, Anderson H, Emdin S, Holmberg L. Ringberg A, et al. Eur J Cancer. 2007 Jan;43(2):291-8. doi: 10.1016/j.ejca.2006.09.018. Epub 2006 Nov 21. Eur J Cancer. 2007. PMID: 17118648 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information